Top Markets
Coin of the day
Hemostemix Inc. Hemostemix Inc.

Hemostemix Inc.

HEM
Classement en actions #32161
Hemostemix Inc., a clinical stage biotechnology company, develops,... Hemostemix Inc., a clinical stage biotechnology company, develops, manufactures, and commercializes blood-derived stem cell therapies for medical conditions in Canada. Its lead product is ACP-01, which is in Phase II clinical trial for the treatment of vascular diseases, such as peripheral arterial disease, angina pectoris, and ischemia, as well as heart failure, ischemic and dilated cardiomyopathy, chronic limb threatening ischemia, vascular dementia, and brain function. The company also develops NCP-01, which is preclinical trial to evaluate effect on neuropathic pain and motor function recovery. Hemostemix Inc. is headquartered in Calgary, Canada.
Prix de l'action
$0.05504527
Dernière synchronisation: 2026-08-17
Capitalisation boursière
$10.89M
Changement (1 jour)
15.38%
Changement (1 an)
-10.64%
Pays
CA
Échange Hemostemix Inc. (HEM)

Catégorie

Le prix HEM avec la capitalisation boursière de B
Hemostemix Inc. Hemostemix Inc.
HEM
$0.05504527
Capitalisation boursière de Hemostemix Inc.(HEM)
Capitalisation boursière: $10.89M
En August 2026, Hemostemix Inc. a une capitalisation boursière de $10.89M. Cela fait de Hemostemix Inc. la 32161st entreprise la plus valorisée au monde selon nos données. La capitalisation boursière, souvent appelée market cap, correspond à la valeur totale des actions en circulation d’une entreprise cotée en bourse, et est couramment utilisée pour évaluer sa valeur.
Historique de la capitalisation boursière de Hemostemix Inc. du 2014 au 2026
HEM par rapport au top 5 des plus populaires stocks
Prix pour HEM L’actif B La capitalisation boursière de B Résultats
Hemostemix Inc. Hemostemix Inc.
$27,604.91 $10.89M
$5.460T +50,149,362.42%
Hemostemix Inc. Hemostemix Inc.
$22,697.55 $10.89M
$4.489T +41,234,231.11%
Hemostemix Inc. Hemostemix Inc.
$20,935.16 $10.89M
$4.141T +38,032,528.66%
Hemostemix Inc. Hemostemix Inc.
$18,041.49 $10.89M
$3.569T +32,775,626.56%
Hemostemix Inc. Hemostemix Inc.
$14,146.04 $10.89M
$2.798T +25,698,813.96%